Egyszerű nézet

dc.contributor.author Gyires Klára
dc.contributor.author Rónai Z. András
dc.contributor.author Zádori Zoltán Sándor
dc.contributor.author Tóth E. Viktória
dc.contributor.author Németh József
dc.contributor.author Szekeres Mária
dc.contributor.author Hunyady László
dc.date.accessioned 2016-01-28T07:44:28Z
dc.date.available 2016-01-28T07:44:28Z
dc.date.issued 2014
dc.identifier 84890290105
dc.identifier.citation pagination=971-978; journalVolume=382; journalIssueNumber=2; journalTitle=MOLECULAR AND CELLULAR ENDOCRINOLOGY;
dc.identifier.uri http://repo.lib.semmelweis.hu//handle/123456789/2656
dc.identifier.uri doi:10.1016/j.mce.2013.10.002
dc.description.abstract The aim of the present study was to analyze whether angiotensin II via the endocannabinoid system can induce gastric mucosal protection, since transactivation of cannabinoid CB1 receptors by angiotensin AT1 receptor in CHO cells was described. Experimental ulcer was induced by acidified ethanol given orally in male Wistar rats, CB1(+/+) wild type and CB1(-/-) knockout mice. The compounds were administered intracerebroventricularly. It was found, that 1. Angiotensin II inhibited the ethanol-induced gastric lesions (11.9-191pmol); the effect of angiotensin II (191pmol) was inhibited by the CB1 receptor inverse agonist AM 251 (1.8nmol) and the inhibitor of diacylglycerol lipase (DAGL), tetrahydrolipstatin (0.2nmol). 2. Angiotensin II exerted gastroprotection in wild type, but not in CB1(-/-) mice. 3. The gastroprotective effect of angiotensin II (191pmol) was reduced by atropine (1mg/kg i.v.) and bilateral cervical vagotomy. In conclusion, stimulation of central angiotensin AT1 receptors via activation of cannabinoid CB1 receptors induces gastroprotection in a DAGL-dependent and vagus-mediated mechanism. Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.
dc.relation.ispartof urn:issn:0303-7207
dc.title Angiotensin II-induced activation of central AT1 receptors exerts endocannabinoid-mediated gastroprotective effect in rats
dc.type Journal Article
dc.date.updated 2015-11-24T13:46:06Z
dc.language.rfc3066 en
dc.identifier.mtmt 2442553
dc.identifier.wos 000331915500019
dc.identifier.pubmed 24145131
dc.contributor.department SE/AOK/I/Farmakológiai és Farmakoterápiás Intézet
dc.contributor.department SE/AOK/I/Élettani Intézet
dc.contributor.department SE/AOK/I/ÉI/MTA-SE Molekuláris Élettani Kutatócsoport
dc.contributor.institution Semmelweis Egyetem


Kapcsolódó fájlok:

A fájl jelenleg csak egyetemi IP címről érhető el.

Megtekintés/Megnyitás

Ez a rekord az alábbi gyűjteményekben szerepel:

Egyszerű nézet